Figure 3From: Thymidine Phosphorylase/β-tubulin III expressions predict the response in Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel PFS and OS curves for TUBB3 negative and positive patients receiving capecitabine plus cisplatin.Back to article page